Management of Asymptomatic CSF Pleocytosis

Initial Diagnostic Approach

The American Academy of Neurology recommends sending CSF PCR for HSV-1, HSV-2, VZV, and enteroviruses immediately, as these account for 90% of viral CNS infections and HSV-2 is the leading identified pathogen in pleocytosis cases 1
The Infectious Diseases Society of America suggests obtaining CSF bacterial culture and Gram stain, as partially treated bacterial meningitis can present with minimal symptoms 1, 2
The Centers for Disease Control and Prevention recommend checking CSF fungal studies and TB testing if risk factors are present, such as immunocompromise or endemic exposure 2, 3
Measuring CSF lactate is also recommended, as levels <2 mmol/L effectively rule out bacterial disease 1

The American Academy of Neurology recommends evaluating for autoimmune/inflammatory conditions, such as ADEM, multiple sclerosis, or other demyelinating diseases, by sending CSF oligoclonal bands and IgG index 1, 2
The National Comprehensive Cancer Network suggests considering malignancy, such as leptomeningeal disease or CNS lymphoma, and performing CSF cytology and flow cytometry if concern is present 2

The American College of Emergency Physicians recommends recognizing atypical presentations, such as Lyme disease with cranial nerve palsy, which often has CSF pleocytosis even without meningeal symptoms, and treating with appropriate antibiotics to prevent sequelae 7
The World Health Organization suggests considering cerebral malaria, although pleocytosis is rare, and not delaying antimalarial treatment if suspected 4

The American Academy of Neurology recommends obtaining brain and spine MRI with contrast if not already done, as neuroimaging changes may reveal autoimmune or structural pathology 5
The American Clinical Neurophysiology Society suggests considering EEG, which may identify subclinical seizure activity or focal abnormalities suggesting underlying pathology 2

The Infectious Diseases Society of America recommends using the CHANCE score to identify high-risk patients requiring aggressive management, which includes parameters such as CSF cell count >100 cells/μL, CSF protein >100 mg/dL, CRP >5 mg/dL, elevated peripheral WBC count, abnormal mental status, and nuchal rigidity 3, 7